David Davey resumes & CV records
Resumes
David Davey
Location:
United States
David O Davey, 7016539 NW 16Th St, Pembroke Pines, FL 33028
David Davey Phones & Addresses
Pembroke Pines, FL
Irvington, NJ
Stamford, CT
18000 3Rd St, Miami, FL 33169 305-6513337
Berwyn, IL
Pompano Beach, FL
Adelphi, MD
Social networks
David O Davey
Linkedin
Mentions for David O Davey
Publications & IP owners
Us Patents
Process For The Preparation Of Imidazoquinoxalinones
US Patent:
5166344, Nov 24, 1992
Filed:
Sep 19, 1991
Appl. No.:
7/762144
Inventors:
David D. Davey - Succasunna NJ
Assignee:
Berlex Laboratories, Inc. - Cedar Knolls NJ
International Classification:
C07D41304
C07D47112
C07D47122
C07D47112
C07D47122
US Classification:
544 586
Abstract:
This invention relates to novel imidazoquinoxalinones and their aza analogs and to a process for their preparation. The compounds of this invention have been found to have inodilatory, vasodilatory, venodilatory and other pharmacologic effects.
Preparation Of Certain 5,6-Dihydro-8-Phenyl-Imidazo[1,5-A]Pyridines
US Patent:
5171858, Dec 15, 1992
Filed:
Apr 18, 1991
Appl. No.:
7/687143
Inventors:
David D. Davey - Succasunna NJ
Assignee:
Schering A.G. - Berlin
International Classification:
C07D47104
US Classification:
546121
Abstract:
This invention relates to novel substituted imidazo-[1,5-a]pyridines, most especially novel 8-phenylimidazo-[1,5-a]pyridines. It also relates to novel intermediates and to a novel process for the preparation of certain of these compounds. The compounds of the invention have been found to have significant cardiotonic, antiarrhythmic, hypotensive, CNS stimulant, and other pharmacological effects.
Imidazoquinoxalinones, Their Aza Analogs And Process For Their Preparation
US Patent:
5055465, Oct 8, 1991
Filed:
May 31, 1989
Appl. No.:
7/359182
Inventors:
David D. Davey - Succasunna NJ
Assignee:
Berlex Laboratories, Inc. - Cedar Knolls NJ
International Classification:
A61K 3154
A61K 31535
C07D41714
C07D41314
A61K 31535
C07D41714
C07D41314
US Classification:
5142282
Abstract:
This invention relates to novel imidazoquinoxalinones and their aza analogs and to a process for their preparation. The compounds of this invention have been found to have inodilatory, vasodilatory, venodilatory and other pharmacologic effects.
Novel Imidazo[1,5-A]Pyridines, Useful As Cardiovascular And Cns Agents
US Patent:
5026712, Jun 25, 1991
Filed:
Apr 12, 1990
Appl. No.:
7/507824
Inventors:
David D. Davey - Succasunna NJ
Assignee:
Schering AG - Berlin
International Classification:
A61K 3141
C07D47104
C07D47104
US Classification:
514300
Abstract:
This invention relates to novel substituted imidazo-[1,5-a]pyridines, most especially novel 8-phenylimidazo-[1,5-a]pyridines. It also relates to novel intermediates and to a novel process for the preparation of certain of these compounds. The compounds of the invention have been found to have significant cardiotonic, antiarrhythmic, hypotensive, CNS stimulant, and other pharmacological effects.
Substituted Sulfonamidobenzamides And Method Of Treating Arrhythmias
US Patent:
4629739, Dec 16, 1986
Filed:
Sep 23, 1985
Appl. No.:
6/778657
Inventors:
David D. Davey - Succasunna NJ
William C. Lumma - Pennsburg PA
Ronald A. Wohl - Morris Plains NJ
William C. Lumma - Pennsburg PA
Ronald A. Wohl - Morris Plains NJ
Assignee:
Schering A.G. - Berlin
International Classification:
A61K 3118
A61K 31535
C07C14375
C07C14380
A61K 31535
C07C14375
C07C14380
US Classification:
514605
Abstract:
Novel substituted sulfonamidobenzamides are described as useful antiarrhythmic agents. Their use in the treatment of cardiac arrhythmias, especially re-entrant arrhythmias, via the prolongation of the action potential of cardiac tissue is provided. Pharmaceutical formulations containing such compounds are also disclosed.
Certain 2-Aminomethyl-3-Phenyl-Pyridine Intermediates For Certain 8-Phenyl-Imidazo[1,5-A]Pyridines
US Patent:
5171859, Dec 15, 1992
Filed:
Apr 18, 1991
Appl. No.:
7/687144
Inventors:
David D. Davey - Succasunna NJ
Assignee:
Schering A.G. - Berlin
International Classification:
C07D21338
US Classification:
546278
Abstract:
This invention relates to novel substituted imidazo[1,5-a]pyridines, most especially novel 8-phenylimidazo[1,5-a]pyridines. It also relates to novel intermediates and to a novel process for the preparation of certain of these compounds. The compounds of the invention have been found to have significant cardiotonic, antiarrhythmic, hypotensive, CNS stimulant, and other pharmacological effects.
Substituted Sulfonamidobenzamides, Antiarrhythmic Agents And Compositions Thereof
US Patent:
4544654, Oct 1, 1985
Filed:
Mar 20, 1984
Appl. No.:
6/591649
Inventors:
David D. Davey - Succasunna NJ
William C. Lumma - Pennsburg PA
Ronald A. Wohl - Morris Plains NJ
William C. Lumma - Pennsburg PA
Ronald A. Wohl - Morris Plains NJ
Assignee:
Schering A.G. - Berlin
International Classification:
A61K 3118
A61K 31535
C07C14375
C07C14380
A61K 31535
C07C14375
C07C14380
US Classification:
514210
Abstract:
Novel substituted sulfonamidobenzamides are described as useful antiarrhythmic agents. Their use in the treatment of cardiac arrhythmias, especially re-entrant arrhythmias, via the prolongation of the action potential of cardiac tissue is provided. Pharmaceutical formulations containing such compounds are also disclosed.
Imidazo[1,2-A]Pyridines, And Process For Their Preparation
US Patent:
4596872, Jun 24, 1986
Filed:
Jun 5, 1985
Appl. No.:
6/741427
Inventors:
David D. Davey - Succasunna NJ
Assignee:
Schering A.G. - Berlin
International Classification:
C07D47102
US Classification:
546121
Abstract:
This invention relates to novel substituted imidazo[1,2-a]pyridines, most especially novel 8-phenylimidazo[1,2-a]pyridines and a process for their preparation. The compounds of the invention have been found to have cardiotonic antiarrhythmic, CNS stimulant, CNS depressant and other pharmacological effects.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.